Breaking News Instant updates and real-time market news.

BIIB

Biogen

$303.78

-1.42 (-0.47%)

04:55
11/29/16
11/29
04:55
11/29/16
04:55

Biogen management to meet with Leerink

Meeting to be held in Boston on November 29 hosted by Leerink.

  • 29

    Nov

BIIB Biogen
$303.78

-1.42 (-0.47%)

11/23/16
PIPR
11/23/16
NO CHANGE
PIPR
Overweight
Piper's Schimmer proclaims amyloid hypothesis is not dead
Piper Jaffray analyst Joshua Schimmer says the failure of Eli Lilly's (LLY) solanezumab is not the final nail in the amyloid hypothesis coffin. Biogen (BIIB) and Eisai's aducanimab study is the most potent approach for amyloid lowering, Schimmer tells investors in a research note. He points out that he was skeptical whether solanezumab's effect was adequate. "Our view of Alzheimer's for amyloid is informed not so much by the extremely sloppy science in that disease, but by consistent cause/effect signals across other amyloidosis," Schimmer writes. He believes today's selloff in shares of Biogen "creates some breathing room." The analyst recommends looking to build a position in Biogen after the stock settles down. Schimmer reiterates an Overweight rating on the shares with a $335 price target. The stock is down 8%, or $24.41, to $293.70 in pre-market trading.
11/23/16
MSCO
11/23/16
NO CHANGE
MSCO
Overweight
Morgan Stanley expects big reversal today in Biogen shares
Morgan Stanley Matthew Harrison expects shares of Biogen (BIIB) to end the trading day flat or slightly higher. The stock is currently down $26.61, or 8%, to $291.50 in pre-market trading. With Biogen's aducanumab more potent than Eli Lilly's solanezumab, the Alzheimer's drug still has potential for success, Harrison tells investors in a research note. He points out that Lilly management noted that "the study results, including many secondary clinical endpoints, directionally favored solanezumab." Harrison sees hope in the amyloid hypothesis. The analyst has an Overweight rating on Biogen.
11/23/16
SBSH
11/23/16
NO CHANGE
Target $305
SBSH
Buy
Citi sees four reasons why Biogen Alzheimer's drug can still work
Citi analyst Robyn Karnauska sees four reasons why Biogen's (BIIB) Alzheimer's drug aducanumab can still work following the failure of Eli Lilly's (LLY) solanezumab. The analyst lists difference in mechanism of action, efficacy in an end-point-dependent manner, patient population and endpoints as why she thinks Biogen's drug can have a different outcome than Lilly's. The analyst has a Neutral rating on Biogen with a $305 price target.
11/23/16
JEFF
11/23/16
NO CHANGE
Target $310
JEFF
Buy
Biogen selloff may be an overreaction, says Jefferies
Jefferies analyst Brian Abrahams believes selloff in shares of Biogen (BIIB) following Eli Lilly's (LLY) Alzheimer's failure may be an overreaction. Signals of activity seen for Lilly's sola "do maintain some possibility" that Biogen's aducanumab could "ultimately make it over the line," Abrahams tells investors in a research note. He keeps a Hold rating on Biogen with a $310 price target, however, viewing the risk/reward as balanced.

TODAY'S FREE FLY STORIES

SFTBF

SoftBank

$60.07

-0.15 (-0.25%)

, S

Sprint

$8.33

0.276 (3.43%)

14:55
12/06/16
12/06
14:55
12/06/16
14:55
Periodicals
SoftBank CEO: $50B U.S. investment to come from $100B tech fund, WSJ says »

Speaking in a Wall Street…

SFTBF

SoftBank

$60.07

-0.15 (-0.25%)

S

Sprint

$8.33

0.276 (3.43%)

TMUS

T-Mobile

$55.02

0.58 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 13

    Dec

  • 04

    Jan

S

Sprint

$8.33

0.2765 (3.43%)

14:55
12/06/16
12/06
14:55
12/06/16
14:55
Technical Analysis
Sprint edges new 52-week high »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 04

    Jan

HMST

HomeStreet

$31.85

2.5 (8.52%)

, UMBF

UMB Financial

$79.36

2.36 (3.06%)

14:55
12/06/16
12/06
14:55
12/06/16
14:55
Hot Stocks
Breaking Hot Stocks news story on HomeStreet, UMB Financial »

HomeStreet to replace UMB…

HMST

HomeStreet

$31.85

2.5 (8.52%)

UMBF

UMB Financial

$79.36

2.36 (3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

UMBF

UMB Financial

$79.36

2.36 (3.06%)

, IM

Ingram Micro

14:55
12/06/16
12/06
14:55
12/06/16
14:55
Hot Stocks
UMB Financial to replace Ingram Micro in S&P 400 as of 12/6 close »

Tianjin Tianhai…

UMBF

UMB Financial

$79.36

2.36 (3.06%)

IM

Ingram Micro

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

GMED

Globus Medical

$23.25

0.235 (1.02%)

, TLN

Taken private

14:55
12/06/16
12/06
14:55
12/06/16
14:55
Hot Stocks
Globus Medical to replace Talen Energy in S&P 400 as of 12/6 close »

Riverstone Holdings is…

GMED

Globus Medical

$23.25

0.235 (1.02%)

TLN

Taken private

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SONC

Sonic

$25.47

-0.02 (-0.08%)

14:52
12/06/16
12/06
14:52
12/06/16
14:52
Conference/Events
Sonic management to meet with Canaccord »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Jan

SFTBF

SoftBank

$60.07

-0.15 (-0.25%)

, S

Sprint

$8.25

0.195 (2.42%)

14:50
12/06/16
12/06
14:50
12/06/16
14:50
Periodicals
Breaking Periodicals news story on SoftBank, Sprint, T-Mobile »

SoftBank's Son…

SFTBF

SoftBank

$60.07

-0.15 (-0.25%)

S

Sprint

$8.25

0.195 (2.42%)

TMUS

T-Mobile

$55.02

0.58 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 13

    Dec

  • 04

    Jan

CRHM

CRH Medical

$5.45

-0.2 (-3.54%)

14:50
12/06/16
12/06
14:50
12/06/16
14:50
Conference/Events
CRH Medical management to meet with Canaccord »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

PLAY

Dave & Buster's

$48.83

1.29 (2.71%)

14:49
12/06/16
12/06
14:49
12/06/16
14:49
Options
Dave & Buster's options imply 9.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 09

    Jan

  • 09

    Jan

RHHBY

Roche

$27.67

0.47 (1.73%)

14:46
12/06/16
12/06
14:46
12/06/16
14:46
Hot Stocks
Genentech says FDA approves Avastin for treatment of type of ovarian cancer »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$762.52

12.02 (1.60%)

, GOOGL

Alphabet Class A

$778.22

13.76 (1.80%)

14:46
12/06/16
12/06
14:46
12/06/16
14:46
Hot Stocks
YouTube says paid out over $1B to music industry in past year »

Alphabet's (GOOG)…

GOOG

Alphabet

$762.52

12.02 (1.60%)

GOOGL

Alphabet Class A

$778.22

13.76 (1.80%)

SNE

Sony

$28.19

0.045 (0.16%)

VIVHY

Vivendi

$18.98

0.225 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jan

S

Sprint

$8.22

0.17 (2.11%)

14:45
12/06/16
12/06
14:45
12/06/16
14:45
Options
Sprint call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 04

    Jan

PBIB

Porter Bancorp

$2.03

-0.44 (-17.81%)

14:44
12/06/16
12/06
14:44
12/06/16
14:44
Hot Stocks
Breaking Hot Stocks news story on Porter Bancorp »

Seidman reports 9.84%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$77.24

0.53 (0.69%)

, CAKE

Cheesecake Factory

$61.40

0.92 (1.52%)

14:37
12/06/16
12/06
14:37
12/06/16
14:37
Hot Stocks
NPD says Q3 foodservice visits fall 1%, quick service restaurant traffic drops »

Market researcher NPD…

DRI

Darden

$77.24

0.53 (0.69%)

CAKE

Cheesecake Factory

$61.40

0.92 (1.52%)

CMG

Chipotle

$368.42

-27.8522 (-7.03%)

YUM

Yum! Brands

$63.41

0.35 (0.56%)

PNRA

Panera Bread

$213.51

-0.16 (-0.07%)

JACK

Jack in the Box

$108.24

1.09 (1.02%)

MCD

McDonald's

$119.04

-0.25 (-0.21%)

DPZ

Domino's Pizza

$167.99

1.7 (1.02%)

QSR

Restaurant Brands

$48.14

0.05 (0.10%)

WEN

Wendy's

$12.85

0.23 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

  • 20

    Dec

  • 09

    Jan

VRA

Vera Bradley

$14.74

0.67 (4.76%)

14:32
12/06/16
12/06
14:32
12/06/16
14:32
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

PLAY

Dave & Buster's

$48.83

1.29 (2.71%)

, AVAV

AeroVironment

$28.58

0.58 (2.07%)

14:31
12/06/16
12/06
14:31
12/06/16
14:31
Earnings
Notable companies reporting after market close »

Notable companies…

PLAY

Dave & Buster's

$48.83

1.29 (2.71%)

AVAV

AeroVironment

$28.58

0.58 (2.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

  • 09

    Jan

  • 09

    Jan

HLT

Hilton

$26.31

0.22 (0.84%)

14:25
12/06/16
12/06
14:25
12/06/16
14:25
Options
Hilton call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Dec

14:25
12/06/16
12/06
14:25
12/06/16
14:25
General news
Masayoshi Son of Softbank agreed to $50 B investment in the U.S. »

Masayoshi Son of Softbank…

14:20
12/06/16
12/06
14:20
12/06/16
14:20
General news
Treasury Option Action: put buying at the long end »

Treasury Option Action:…

14:18
12/06/16
12/06
14:18
12/06/16
14:18
General news
Averages at best levels of day in afternoon trading »

Stocks have taken a leg…

IL

Intralinks

$13.22

1.95 (17.30%)

14:18
12/06/16
12/06
14:18
12/06/16
14:18
Downgrade
Intralinks rating change  »

Intralinks downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

S

Sprint

$7.96

-0.09 (-1.12%)

, TMUS

T-Mobile

$55.02

0.58 (1.07%)

14:17
12/06/16
12/06
14:17
12/06/16
14:17
Hot Stocks
Breaking Hot Stocks news story on Sprint, T-Mobile, SoftBank »

Sprint, T-Mobile shares…

S

Sprint

$7.96

-0.09 (-1.12%)

TMUS

T-Mobile

$55.02

0.58 (1.07%)

SFTBF

SoftBank

$60.07

-0.15 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 13

    Dec

  • 04

    Jan

SFTBF

SoftBank

$60.07

-0.15 (-0.25%)

14:16
12/06/16
12/06
14:16
12/06/16
14:16
Hot Stocks
Trump says SoftBank has agreed to invest $50B in U.S. »

President-elect Donald…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
12/06/16
12/06
14:16
12/06/16
14:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:16
12/06/16
12/06
14:16
12/06/16
14:16
Technical Analysis
NASDAQ market internals summary »

Volume is heavier than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.